Sapanisertib in Treating Patients With Stage IV or Recurrent Lung Cancer

Clinical trial NCT02417701 · COMPLETED

Trial details

NCT number: NCT02417701
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Lung Squamous Cell Carcinoma Stage IV Lung Squamous Cell Carcinoma AJCC v7

Start date: 2016-10-06
Primary completion: 2020-12-28
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.